BALAXI PHARMACEUTICALS
Back to Balance Sheet
|
BALAXI PHARMACEUTICALS Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹310 Cr | ₹258 Cr | ₹240 Cr | ₹176 Cr | ₹100 Cr |
What is the latest Total Liabilities ratio of BALAXI PHARMACEUTICALS ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹310 Cr |
| Mar2024 | ₹258 Cr |
| Mar2023 | ₹240 Cr |
| Mar2022 | ₹176 Cr |
| Mar2021 | ₹100 Cr |
How is Total Liabilities of BALAXI PHARMACEUTICALS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹310 Cr | 20.13 | |
| Mar2024 | ₹258 Cr | 7.79 | |
| Mar2023 | ₹240 Cr | 35.81 | |
| Mar2022 | ₹176 Cr | 77.04 | |
| Mar2021 | ₹100 Cr | - | |
Compare Total Liabilities of peers of BALAXI PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BALAXI PHARMACEUTICALS | ₹134.6 Cr | 0.9% | -8.9% | -65.5% | Stock Analytics | |
| ADANI ENTERPRISES | ₹261,044.0 Cr | 8.4% | -8.8% | -10.2% | Stock Analytics | |
| REDINGTON | ₹21,240.8 Cr | 8.4% | 1.2% | 17.9% | Stock Analytics | |
| MMTC | ₹9,763.5 Cr | 1.9% | -3.6% | -0.3% | Stock Analytics | |
| HONASA CONSUMER | ₹8,993.2 Cr | 1.5% | -5.1% | 10.1% | Stock Analytics | |
| LLOYDS ENTERPRISES | ₹8,878.4 Cr | 10.1% | -3.3% | 7.4% | Stock Analytics | |
BALAXI PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BALAXI PHARMACEUTICALS | 0.9% |
-8.9% |
-65.5% |
| SENSEX | -0.1% |
-2.9% |
7.5% |
You may also like the below Video Courses